Explain this page
Arphra AIPlain-English read on Boston Scientific Corporation’s valuationTransactions
43
0 buys · 43 sells
Bought
$0
Open market
Sold
$122.13M
Open market
Net flow
−$122.13M
Buys − sells
Transactions
| Insider | Role | Action | Shares | Price | Value | Trade date | Filing |
|---|---|---|---|---|---|---|---|
| Mahoney Michael F | director, officer: Chairman, President & CEO | Sell | 1,200 | $94.06 | $112.87K | Feb 02, 2026 | Feb 03, 2026 |
| Mahoney Michael F | director, officer: Chairman, President & CEO | Sell | 159,701 | $93.49 | $14.93M | Feb 02, 2026 | Feb 03, 2026 |
| Butcher Arthur C | officer: EVP& Grp Pres, MedSurg & APAC | Sell | 17,313 | $101.55 | $1.76M | Dec 01, 2025 | Dec 02, 2025 |
| Zane Ellen M | director | Sell | 12,891 | $98.28 | $1.27M | Nov 06, 2025 | Nov 06, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 3,600 | $100.75 | $362.69K | Nov 03, 2025 | Nov 04, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 29,472 | $99.14 | $2.92M | Nov 03, 2025 | Nov 04, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 16,928 | $99.76 | $1.69M | Nov 03, 2025 | Nov 04, 2025 |
| Zane Ellen M | director | Sell | 2,901 | $102.24 | $296.6K | Oct 28, 2025 | Oct 28, 2025 |
| Zane Ellen M | director | Sell | 9,990 | $101.13 | $1.01M | Oct 27, 2025 | Oct 28, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 8,245 | $98.91 | $815.48K | Oct 01, 2025 | Oct 01, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 41,755 | $98.38 | $4.11M | Oct 01, 2025 | Oct 01, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 28,170 | $105.85 | $2.98M | Sep 02, 2025 | Sep 03, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 21,830 | $104.89 | $2.29M | Sep 02, 2025 | Sep 03, 2025 |
| Butcher Arthur C | officer: EVP& Grp Pres, MedSurg & APAC | Sell | 17,313 | $104.63 | $1.81M | Aug 01, 2025 | Aug 04, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 50,000 | $104.63 | $5.23M | Aug 01, 2025 | Aug 04, 2025 |
| FUJIMORI YOSHIAKI | director | Sell | 2,901 | $106.99 | $310.38K | Jul 29, 2025 | Jul 30, 2025 |
| LUDWIG EDWARD J | director | Sell | 4,000 | $106.03 | $424.12K | Jul 25, 2025 | Jul 28, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 50,000 | $106.97 | $5.35M | Jul 01, 2025 | Jul 02, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 56,372 | $102.88 | $5.8M | Jun 04, 2025 | Jun 04, 2025 |
| Mahoney Michael F | director, officer: Chairman, President & CEO | Sell | 89,921 | $103.39 | $9.3M | Jun 02, 2025 | Jun 03, 2025 |
| Mahoney Michael F | director, officer: Chairman, President & CEO | Sell | 74,522 | $104.05 | $7.75M | Jun 02, 2025 | Jun 03, 2025 |
| LUDWIG EDWARD J | director | Sell | 4,000 | $104.59 | $418.37K | May 29, 2025 | May 30, 2025 |
| Brown Vance R | officer: SVP, GC and Corp. Secretary | Sell | 4,826 | $106.42 | $513.58K | May 21, 2025 | May 22, 2025 |
| Sorenson John Bradley | officer: EVP, Global Operations | Sell | 4,572 | $104.54 | $477.96K | May 05, 2025 | May 06, 2025 |
| Mahoney Michael F | director, officer: Chairman, President & CEO | Sell | 73,161 | $102.92 | $7.53M | May 01, 2025 | May 05, 2025 |
| Mahoney Michael F | director, officer: Chairman, President & CEO | Sell | 91,282 | $102.13 | $9.32M | May 01, 2025 | May 05, 2025 |
| Butcher Arthur C | officer: EVP& Grp Pres, MedSurg & APAC | Sell | 17,314 | $102.06 | $1.77M | May 01, 2025 | May 05, 2025 |
| Brown Vance R | officer: SVP, GC and Corp. Secretary | Sell | 4,826 | $95.09 | $458.9K | Apr 21, 2025 | Apr 22, 2025 |
| Mahoney Michael F | director, officer: Chairman, President & CEO | Sell | 164,442 | $100.01 | $16.45M | Apr 01, 2025 | Apr 02, 2025 |
| Brown Vance R | officer: SVP, GC and Corp. Secretary | Sell | 4,826 | $100.85 | $486.7K | Mar 21, 2025 | Mar 24, 2025 |
| Woodworth Emily | officer: SVP, Global Controller and CAO | Sell | 482 | $104.63 | $50.43K | Mar 04, 2025 | Mar 05, 2025 |
| Woodworth Emily | officer: SVP, Global Controller and CAO | Sell | 7,149 | $104.97 | $750.46K | Mar 03, 2025 | Mar 05, 2025 |
| Woodworth Emily | officer: SVP, Global Controller and CAO | Sell | 9,887 | $101.13 | $999.87K | Feb 28, 2025 | Mar 03, 2025 |
| Mirviss Jeffrey B. | officer: EVP&Pres, Periph Intervent | Sell | 2,688 | $104.00 | $279.55K | Feb 25, 2025 | Feb 25, 2025 |
| Mirviss Jeffrey B. | officer: EVP&Pres, Periph Intervent | Sell | 4,675 | $104.25 | $487.37K | Feb 24, 2025 | Feb 25, 2025 |
| Zane Ellen M | director | Sell | 13,586 | $104.23 | $1.42M | Feb 24, 2025 | Feb 24, 2025 |
| Brown Vance R | officer: SVP, GC and Corp. Secretary | Sell | 4,826 | $104.64 | $504.99K | Feb 21, 2025 | Feb 21, 2025 |
| Sorenson John Bradley | officer: EVP, Global Operations | Sell | 3,303 | $105.19 | $347.44K | Feb 19, 2025 | Feb 19, 2025 |
| Brennan Daniel J. | officer: EVP and CFO | Sell | 67,333 | $105.24 | $7.09M | Feb 19, 2025 | Feb 19, 2025 |
| Mirviss Jeffrey B. | officer: EVP&Pres, Periph Intervent | Sell | 1,510 | $105.35 | $159.08K | Feb 19, 2025 | Feb 19, 2025 |
| Brennan Daniel J. | officer: EVP and CFO | Sell | 14,630 | $104.67 | $1.53M | Feb 18, 2025 | Feb 19, 2025 |
| Sorenson John Bradley | officer: EVP, Global Operations | Sell | 2,657 | $104.41 | $277.42K | Feb 18, 2025 | Feb 19, 2025 |
| Brennan Daniel J. | officer: EVP and CFO | Sell | 2,900 | $104.08 | $301.82K | Feb 18, 2025 | Feb 19, 2025 |
By insider
- Mahoney Michael F−$65.39Mdirector, officer: Chairman, President & CEO0B · 7S
- Fitzgerald Joseph Michael−$31.55Mofficer: EVP & Group Pres, Cardiology0B · 10S
- Brennan Daniel J.−$8.92Mofficer: EVP and CFO0B · 3S
- Butcher Arthur C−$5.34Mofficer: EVP& Grp Pres, MedSurg & APAC0B · 3S
- Zane Ellen M−$3.99Mdirector0B · 4S
- Brown Vance R−$1.96Mofficer: SVP, GC and Corp. Secretary0B · 4S
- Woodworth Emily−$1.8Mofficer: SVP, Global Controller and CAO0B · 3S
- Sorenson John Bradley−$1.1Mofficer: EVP, Global Operations0B · 3S
- Mirviss Jeffrey B.−$926Kofficer: EVP&Pres, Periph Intervent0B · 3S
- LUDWIG EDWARD J−$842.49Kdirector0B · 2S
- FUJIMORI YOSHIAKI−$310.38Kdirector0B · 1S
Beneficial ownership filings
Schedule 13D / 13G — investors holding more than 5% of BSX-US.
DB · acquisition_ownership10
| Filed | Reporting person | Form | Type | Aggregate owned | % Class | Sole voting | Shared voting | Citizenship | |
|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2022 | Boston Scientific Corporation | — | CO | — | +8.00% | 543.97K | 0 | — | SEC → |
| Feb 09, 2022 | FMR LLC | — | HC | — | +7.02% | 12.18M | 0 | Delaware | SEC → |
| Feb 09, 2022 | Abigail P. Johnson | — | IN | — | +7.02% | 0 | 0 | United States of America | SEC → |
| Feb 09, 2022 | The Vanguard Group - 23-1945930 | — | IA | — | +7.83% | 0 | 2.24M | Pennsylvania | SEC → |
| Feb 08, 2022 | (1) BlackRock, Inc. | — | HC | — | +9.00% | 113.56M | 0 | Delaware | SEC → |
| Feb 04, 2022 | Wellington Group Holdings LLP | — | HC | — | +5.22% | 0 | 68.68M | — | SEC → |
| Feb 04, 2022 | Wellington Management Group LLP | — | HC | — | +5.22% | 0 | 68.68M | — | SEC → |
| Feb 04, 2022 | Wellington Investment Advisors Holdings LLP | — | HC | — | +5.22% | 0 | 68.68M | — | SEC → |
| Feb 03, 2022 | Boston Scientific Corporation | — | CO | — | +36.00% | 0 | 0 | Delaware | SEC → |
| Feb 02, 2022 | 04-2747644 | — | IA | — | +6.10% | 78.27M | 0 | Delaware | SEC → |
Top 10 holders · 8 quarters
13F position evolutionNo 13F history in
institutional_holders for BSX-US.